BRITISH JOURNAL OF OPHTHALMOLOGY

Scope & Guideline

Pioneering Discoveries in Ocular Science

Introduction

Welcome to your portal for understanding BRITISH JOURNAL OF OPHTHALMOLOGY, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN0007-1161
PublisherBMJ PUBLISHING GROUP
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1941 to 2024
AbbreviationBRIT J OPHTHALMOL / Br. J. Ophthalmol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressBRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND

Aims and Scopes

The British Journal of Ophthalmology focuses on advancing the field of ophthalmology through high-quality research that encompasses a wide array of topics related to eye health and diseases. Its scope includes clinical studies, experimental research, and innovative methodologies that enhance the understanding and treatment of ocular conditions.
  1. Clinical Ophthalmology:
    The journal emphasizes studies that investigate clinical outcomes, treatment effectiveness, and patient management strategies for various ocular diseases, including glaucoma, diabetic retinopathy, and age-related macular degeneration.
  2. Innovative Surgical Techniques:
    Research on novel surgical techniques and technologies, such as advanced cataract surgery methods, retinal detachment repair techniques, and the use of intraocular devices, is a core focus area.
  3. Genetics and Molecular Ophthalmology:
    There is a significant emphasis on genetic studies related to inherited retinal diseases, providing insights into gene mutations and their implications for patient care.
  4. Artificial Intelligence in Ophthalmology:
    The journal explores the integration of artificial intelligence and machine learning in diagnosing and managing ocular diseases, reflecting a growing trend towards technological innovation in the field.
  5. Epidemiology and Public Health:
    Epidemiological studies that assess the prevalence, risk factors, and societal impact of ocular diseases, particularly in diverse populations, are also a significant focus.
The British Journal of Ophthalmology is currently witnessing emerging trends that reflect advancements in technology and a deeper understanding of ocular health. These themes are gaining traction and are likely to shape future research directions.
  1. Telemedicine and Remote Patient Monitoring:
    The rise of telemedicine in ophthalmology is increasingly evident, with studies exploring its effectiveness in managing patient care and screening for ocular diseases, particularly in the context of the COVID-19 pandemic.
  2. Myopia Control Strategies:
    There is a notable increase in research focusing on myopia control, including the efficacy of various interventions such as atropine, orthokeratology, and the impact of environmental factors, reflecting a growing public health concern.
  3. Artificial Intelligence Applications:
    The application of artificial intelligence in diagnosing and managing ocular diseases is a rapidly growing field, with numerous studies developing algorithms for automated detection of conditions such as diabetic retinopathy and glaucoma.
  4. Ocular Surface Disease and Dry Eye Research:
    Research on ocular surface diseases, particularly dry eye syndrome, is gaining prominence, focusing on new treatment modalities and the impact of systemic health on ocular surface integrity.
  5. Genetic and Genomic Studies:
    An increasing trend towards understanding the genetic basis of ocular diseases is evident, with studies investigating gene therapy and genetic predispositions to conditions like retinitis pigmentosa and age-related macular degeneration.

Declining or Waning

While the British Journal of Ophthalmology continues to publish a wide range of research, some themes appear to be declining in prominence over recent years. This may be reflective of shifting research priorities or advancements in understanding certain areas.
  1. Traditional Pharmacological Studies:
    There seems to be a decreasing focus on traditional pharmacological studies comparing established treatments for common ocular conditions, as newer therapeutic approaches and technologies gain traction.
  2. Basic Science Research:
    Research that primarily focuses on basic science without direct clinical application appears to be waning, as there is a stronger push towards translational studies that connect laboratory findings with clinical practice.
  3. Longitudinal Studies on Rare Ocular Conditions:
    The frequency of longitudinal studies focusing on rare ocular diseases has declined, possibly due to the challenges in recruitment and the limited patient populations available for such research.

Similar Journals

Seminars in Ophthalmology

Advancing the Frontiers of Vision Science
Publisher: TAYLOR & FRANCIS INCISSN: 0882-0538Frequency: 6 issues/year

Seminars in Ophthalmology is a prestigious journal published by Taylor & Francis Inc, dedicated to advancing knowledge in the field of ophthalmology and related medical areas. Established in 1986, this journal has consistently provided a platform for high-quality research and insights, supporting the community with its impactful publications. With an impressive ranking of #55 out of 137 in the Ophthalmology category, the journal currently holds a Q2 quartile in both ophthalmology and miscellaneous medicine as of 2023, reflecting its significant contribution to the discipline. Researchers and practitioners can access a wealth of information covering a comprehensive range of topics, bolstering both clinical practice and academic inquiry. While not an open-access publication, Seminars in Ophthalmology remains a crucial resource for advancing ophthalmic research, fostering collaboration, and disseminating valuable findings in a rapidly evolving specialty.

KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE

Illuminating Insights in Eye Health.
Publisher: GEORG THIEME VERLAG KGISSN: 0023-2165Frequency: 12 issues/year

Klinische Monatshefte für Augenheilkunde is a distinguished peer-reviewed journal published by Georg Thieme Verlag KG, dedicated to advancing knowledge in the field of ophthalmology and general medicine. With an ISSN of 0023-2165 and an E-ISSN of 1439-3999, this journal has been a reputable platform for researchers and clinicians since its inception in 1963, continuing its impactful contributions through to 2024. Recognized in the Q3 quartile for both Medicine (miscellaneous) and Ophthalmology, this journal serves as a vital resource for those involved in ocular health, offering insights into clinical practices, recent advancements, and essential research findings. Despite its traditional publishing model, the journal retains a significant role in the academic community, as evidenced by its current Scopus ranking of #90/137 in the field of Ophthalmology. It is an essential read for professionals and students aiming to stay at the forefront of ophthalmic research and clinical innovations.

CURRENT EYE RESEARCH

Connecting Disciplines for Visionary Discoveries
Publisher: TAYLOR & FRANCIS INCISSN: 0271-3683Frequency: 12 issues/year

CURRENT EYE RESEARCH is a prestigious academic journal published by Taylor & Francis Inc, focusing on advancing the field of ophthalmology and its intersection with cellular and molecular neuroscience. Since its inception in 1981, this journal has provided a vital platform for original research, reviews, and technical notes, presenting a wealth of knowledge to practitioners and researchers alike. With an impressive 2023 impact factor reflected in its ranking of Q2 in Ophthalmology and Q2 in Sensory Systems, and a Q3 ranking in Cellular and Molecular Neuroscience, CURRENT EYE RESEARCH plays a crucial role in fostering interdisciplinary collaboration and innovation. The journal is indexed in Scopus, where it holds strong positions in both the Medicine and Neuroscience categories, enhancing its visibility and reach. Researchers and professionals in these fields can access cutting-edge findings and contribute to the ongoing discourse surrounding eye health, making it an essential resource for anyone invested in advancing knowledge and treatment in ophthalmic science.

Ophthalmology Science

Bridging Research and Clinical Excellence
Publisher: ELSEVIERISSN: 2666-9145Frequency:

Ophthalmology Science is a premier journal published by Elsevier, dedicated to advancing the field of ophthalmology through innovative research and clinical insights. With an impact factor that positions it in the Q1 category of ophthalmology journals, it stands out as a crucial resource for researchers, clinicians, and students alike. The journal, indexed under ISSN 2666-9145, covers a wide array of topics relevant to eye care, encompassing the latest breakthroughs in diagnostics, therapeutics, and surgical techniques. Operating in the United States from its office in Amsterdam, the journal aims to bridge the gap between laboratory findings and clinical applications, contributing to improved patient outcomes globally. The converged years from 2021 to 2024 reflect its commitment to providing timely and impactful research that shapes the future of ophthalmic practice. Make sure to explore the open access options available for wider dissemination of your work and to stay ahead in the evolving landscape of ophthalmology.

Translational Vision Science & Technology

Transforming Insights into Impact in Vision Science
Publisher: ASSOC RESEARCH VISION OPHTHALMOLOGY INCISSN: 2164-2591Frequency: 6 issues/year

Translational Vision Science & Technology is a premier open access journal dedicated to the advancement of the field of ophthalmology and biomedical engineering. Published by the Association for Research in Vision and Ophthalmology, Inc., this journal has established itself as a leading source of high-quality research since its inception in 2013, achieving a remarkable impact factor reflective of its influential contribution to the field. With an impressive ranking of #21 in Ophthalmology and #120 in Biomedical Engineering within the Scopus database, it sits within the prestigious Q1 quartile for both categories as of 2023, further validating its significance. The journal's scope encompasses a wide variety of topics focused on the intersection of ophthalmological science and technological innovation, welcoming contributions that promote the understanding and treatment of visual disorders. Available as an Open Access publication since 2016, it ensures that cutting-edge research is freely accessible to researchers, practitioners, and students worldwide, facilitating the rapid dissemination of knowledge essential for the advancement of vision science.

Turk Oftalmoloji Dergisi-Turkish Journal of Ophthalmology

Elevating Standards in Ophthalmology Research
Publisher: GALENOS PUBL HOUSEISSN: 1300-0659Frequency: 6 issues/year

Turk Oftalmoloji Dergisi - Turkish Journal of Ophthalmology is a premier peer-reviewed publication dedicated to the field of ophthalmology, published by GALENOS PUBL HOUSE. Since its inception in 1997, this Open Access journal has championed the dissemination of high-quality research, fostering an inclusive environment for sharing knowledge and advancements in eye health. With an ISSN of 1300-0659 and an E-ISSN of 2147-2661, the journal serves as a vital resource for researchers, clinicians, and students interested in the latest findings and innovations in ophthalmic sciences. Although its coverage in Scopus has been discontinued since 2017, the journal has garnered a significant rank of 80 out of 114 in the field of Medicine – Ophthalmology, highlighting its relevance and impact within the discipline. Operating out of Istanbul, Turkey, the Turkish Journal of Ophthalmology continues to be a crucial platform for ophthalmologists and researchers to publish their work and advance the understanding of ocular health.

Ophthalmologie

Transforming Knowledge into Visionary Solutions
Publisher: SPRINGER HEIDELBERGISSN: 2731-720XFrequency: 12 issues/year

Ophthalmologie is a distinguished journal published by Springer Heidelberg, specializing in the broad and evolving field of ophthalmology. With an ISSN of 2731-720X and an E-ISSN of 2731-7218, the journal serves as a pivotal platform for disseminating cutting-edge research and clinical advancements in the realm of eye health. As of 2023, it ranks in the third quartile (Q3) within both the general medicine and ophthalmology categories, reflecting its substantial contribution to the academic community and the field's knowledge base. The journal aims to foster collaboration among researchers, medical professionals, and students by offering innovative findings that enhance understanding and treatment of ocular diseases. By nurturing high-quality scholarly discussions, Ophthalmologie plays an essential role in the ongoing development of therapeutic strategies and ophthalmic techniques that ultimately benefit patient care globally. This commitment to excellence is evident as it continues to evolve through its convergence from 1992 to 2023, staying relevant in an ever-changing scientific environment.

SURVEY OF OPHTHALMOLOGY

Leading the Conversation in Ophthalmic Excellence
Publisher: ELSEVIER SCIENCE INCISSN: 0039-6257Frequency: 6 issues/year

SURVEY OF OPHTHALMOLOGY is a premier journal published by Elsevier Science Inc, dedicated to advancing knowledge in the field of ophthalmology. With an impact factor reflective of its high-quality research—ranking 7th out of 137 in the Scopus category for medicine and ophthalmology, this journal maintains a prestigious Q1 categorization in its field for 2023. Since its inception in 1956, the journal has provided comprehensive reviews and original articles covering various aspects of ophthalmic research and clinical practice, supporting the ongoing education of researchers, professionals, and students alike. While open access options are not available, the journal remains an essential resource for the latest developments, discoveries, and expert insights that shape the future of eye health. Based in the United States, at STE 800, 230 Park Ave, New York, NY 10169, the journal continues a legacy of excellence in ophthalmology until 2024 and beyond, making it a pivotal element of scholarly discourse in this vital medical discipline.

Eye and Vision

Illuminating the path to vision science breakthroughs.
Publisher: BMCISSN: 2326-0246Frequency: 1 issue/year

Eye and Vision, published by BMC, is a leading open-access journal dedicated to the dynamic field of ophthalmology and visual sciences. With its ISSN 2326-0246 and E-ISSN 2326-0254, the journal has established itself as a premier platform for innovative research and clinical studies, achieving impressive rankings in 2023 as Q1 in both Health Professions (Miscellaneous) and Ophthalmology categories. The journal's commitment to accessible knowledge since its transition to open access in 2015 enhances its global reach, allowing researchers, clinicians, and students to share and access top-tier studies and advancements in the field. Located in the United Kingdom and delivering influential insights from 2014 through to 2024, Eye and Vision holds significant relevance, with a Scopus ranking placing it in the 99th percentile for Health Professions and the 93rd percentile for Ophthalmology, making it an essential resource for those looking to stay at the forefront of eye research and vision science.

Journal of Ophthalmology

Fostering Collaboration for a Brighter Vision
Publisher: HINDAWI LTDISSN: 2090-004XFrequency: 1 issue/year

The Journal of Ophthalmology, published by HINDAWI LTD, is an esteemed open-access journal that has been disseminating significant research in the field of ophthalmology since 2009. With an ISSN of 2090-004X and an E-ISSN of 2090-0058, this journal facilitates global access to cutting-edge studies, making it an essential resource for researchers, clinicians, and students alike. Ranked in the Q2 category of ophthalmology for 2023, the journal holds a commendable position with a Scopus rank of #37 out of 137 in its field, placing it in the 73rd percentile. The journal encompasses a variety of topics such as clinical advancements, surgical techniques, and innovative technologies in eye care, aiming to advance scientific knowledge and clinical practice in ophthalmology. By providing a platform for both novel research and comprehensive reviews, the Journal of Ophthalmology is instrumental in fostering collaboration and scholarly communication within the global eye health community, and its commitment to open access ensures that impactful research reaches a wide audience without barriers.